This study is not yet accepting patients
PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US
Summary
- Eligibility
- for females (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCLA UCSD
- Dates
- study startedestimated completion
- Principal Investigator
- by Brookie Best, PharmD, MAS (ucsd)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Health
- Brookie Best, PharmD, MAS (ucsd)
Dr. Brookie Best is a Professor of Clinical Pharmacy and Pediatrics and the Associate Dean for Pharmacy Education at the University of California (UC), San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) and the Department of Pediatrics, School of Medicine (SOM).
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- ID
- NCT04582266
- Study Type
- Observational
- Last Updated